MeSH tree: D12.776.124.486.485.114.224.060.813
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating multiple sclerosis.
Sep 25, 2025
0
22
New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of multiple sclerosis (MS) relapses ...
Sep 23, 2025
0
15
A simple treatment algorithm may help reduce treatment disparities for Hispanic and Black people with multiple sclerosis (MS), according to a preliminary study released today, March 3, 2025, that will be presented at the ...
Mar 3, 2025
0
11
New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, ...
Sep 17, 2024
0
49
Researchers at the Medical College of Georgia at Augusta University are searching for a better way to understand why many men with prostate cancer end up with Alzheimer's disease, and whether it's the standard hormone therapy ...
Aug 29, 2024
0
67
Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study presenting ...
Mar 4, 2024
0
32
Researchers at Duke University School of Medicine, studying multiple sclerosis (MS) in mice, identified a protein that could reshape the understanding of MS treatments.
Oct 16, 2023
0
51
A best treatment pathway has been identified for people with multiple sclerosis (MS) whose current medication puts them at risk of a serious brain infection.
Jun 5, 2023
0
51
In an editorial in the journal Frontiers in Neurology, two leading multiple sclerosis (MS) experts are advocating for genetic testing to identify MS patients who are at higher risk of developing a devastating side effect ...
Mar 16, 2023
0
144
New research has confirmed a strong link between four genetic mutations and progressive multifocal leukoencephalopathy (PML), a rare but often fatal brain infection that can be triggered by dozens of FDA-approved drugs.
Dec 14, 2022
1
94
